EDAP EDAP TMS SA

NEUTRAL Impact: 4/10 8-K
Horizon weeks Filed May 29, 2026 Processed 15d 3h ago SEC 0001171843-26-003773
8-K context-dependent: Items 8.01
Latest settled — T+5d
EDAP ▲ +6.25% at T+5d
NEUTRAL call ✓ call won +6.25% · α vs SPY +8.77% · entry $4.32 → $4.59
Next anchor: T+20d in 16d
Currently $4.77 · +10.42% from $4.32 entry
Entry anchored
May 29, 2026
via day open
T+1d
+10.65%
call +10.65% · α +10.39%
$4.78
settled 12d ago
T+5d
+6.25%
call +6.25% · α +8.77%
$4.59
settled 8d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

EDAP TMS SA announced it will operate under the new corporate name 'FocalTherics' and change its Nasdaq ticker to 'FOCL' effective June 1, 2026. The company also intends to classify its legacy ESWL and Distribution segments as discontinued operations beginning Q2 2026, concentrating on its robotic HIFU focal therapy business. An Investor Day is scheduled for June 1 to discuss strategy. The filing contains no financial data, and the historical record shows prior neutral reports on this ticker have been directionally unhelpful, though the name/segmentation pivot is a notable strategic move.

Actionable Insight

Monitor the Investor Day on June 1 for quantitative guidance on the HIFU growth trajectory and the financial impact of discontinuing ESWL/Distribution segments. Watch Q2 2026 filing for restated historicals and segment-level financial breakdowns. The ticker change to FOCL may prompt re-indexing and retail attention.

Key Facts

  • Ticker symbol changes from EDAP to FOCL effective June 1, 2026.
  • Company will operate under new corporate name 'FocalTherics'.
  • Legal name remains EDAP TMS S.A.; shareholder vote required for legal name change.
  • ESWL and Distribution segments to be classified as discontinued operations beginning Q2 2026.
  • Investor Day scheduled for June 1, 2026 at 8:00 AM ET.
  • No financial figures or guidance provided in the filing.
  • CUSIP number unchanged; no shareholder action required for name/ticker change.

Financial Impact

No financial figures disclosed; the strategic pivot to focus on robotic HIFU could materially reshape the revenue and cost structure once the discontinued operations classification is implemented in Q2 2026 financials.

revenueoperating incomesegment reporting

Risk Factors

  • Execution risk in transitioning to a pure-play focal therapy company from legacy segments.
  • Potential for customer or distributor disputes during the discontinuation process.
  • No financial details provided – the strategic benefit may take quarters to materialize.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
67% bullish (9 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-003773
Exhibit: exh_991.htm0001171843-26-003773
Document: 0001171843-26-003773-index-headers.html0001171843-26-003773
Document: 0001171843-26-003773-index.html0001171843-26-003773
Document: 0001171843-26-003773.txt0001171843-26-003773
11 reports for EDAP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EDAP — sortable, filterable
Type Now
May 29, 2026
15d ago
8-K
NEUTRAL ★ 4/10
$4.32 $4.59▲ +6.25%▲ +8.77%$4.77 (+10.42%)
May 14, 2026
4w ago
DEFA14A
BEARISH ★ 6/10
$4.13 $4.33▼ −4.84%▼ −5.56%$4.77 (−15.50%)
May 14, 2026
4w ago
DEFA14A
NEUTRAL ★ 3/10
$4.13 $4.33▲ +4.84%▲ +5.56%$4.77 (+15.50%)
May 14, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$4.13 $4.33▲ +4.84%▲ +5.56%$4.77 (+15.50%)
May 7, 2026
5w ago
8-K
MIXED ★ 6/10
$4.16 $4.16· 0.00%▼ −1.50%$4.77 (+14.66%)
Apr 16, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$3.59 $3.29▼ −8.36%▼ −9.34%$4.77 (+32.87%)
Apr 1, 2026
10w ago
EFFECT
NEUTRAL ★ 4/10
$3.53 $3.36▼ −4.82%▼ −8.58%$4.77 (+35.13%)
Mar 27, 2026
11w ago
S-3/A
NEUTRAL ★ 4/10
$3.73 $3.46▼ −7.24%▼ −11.10%$4.77 (+27.88%)
Mar 25, 2026
11w ago
S-3
NEUTRAL ★ 5/10
$3.77 $3.39▼ −10.08%▼ −11.71%$4.77 (+26.53%)
Mar 25, 2026
11w ago
Press Release
MIXED ★ 6/10
$3.71 $3.53▼ −4.85%▼ −4.61%$4.77 (+28.57%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (46h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access